|
|
Article: News and FDA Updates for Thermo Fisher (NYSE:TMO), Incyte (Nasdaq:INCY), OSI Pharma. (NASDAQ:OSIP) and Auxilium (NASDAQ:AUXL).
- Article from:
- M2 Presswire
- Article date:
- July 22, 2009
CopyrightCOPYRIGHT 2009 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-22 July 2009-BiomedReports: News and FDA Updates for Thermo Fisher (NYSE:TMO), Incyte (Nasdaq:INCY), OSI Pharma. (NASDAQ:OSIP) and Auxilium (NASDAQ:AUXL).(C)1994-2009 M2 COMMUNICATIONS
RDATE:22072009
Pasadena, CA -- BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.
A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com
On 21/07/09, ...
Related newspaper, magazine, and journal articles:
|
|
Article: RXi Pharmaceuticals Licenses Rights to RNAi Sequences to Genes ...
Business Wire;
December 14, 2007 ;
700+ words
... ... subsidiary of CytRx Corporation (NASDAQ: CYTR), today announced ... entered into an agreement with Thermo Fisher Scientific Inc. (NYSE ... RNAi sequences disclosed by Thermo Fisher Scientific in its pending ... Executive Officer of RXi. About Thermo Fisher Scientific Thermo ...
|
|